Janna Sand-Dejmek
Director/Miembro de la Junta en WNTRESEARCH AB .
Perfil
Janna Sand-Dejmek is currently the Chairman at Sand Medical AB and Director at Wntresearch AB.
Previously, she worked as the Head-Clinical Oncology Development Division at Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
She completed her undergraduate degree at the University of Lund.
Cargos activos de Janna Sand-Dejmek
Empresas | Cargo | Inicio |
---|---|---|
WNTRESEARCH AB | Director/Miembro de la Junta | - |
Sand Medical AB
Sand Medical AB Medical/Nursing ServicesHealth Services Sand Medical AB provides medical care services. The private company is based in Stockholm, Sweden. | Presidente | - |
Antiguos cargos conocidos de Janna Sand-Dejmek.
Empresas | Cargo | Fin |
---|---|---|
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Corporate Officer/Principal | - |
Formación de Janna Sand-Dejmek.
University of Lund | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
WNTRESEARCH AB | Health Technology |
Empresas privadas | 2 |
---|---|
Sand Medical AB
Sand Medical AB Medical/Nursing ServicesHealth Services Sand Medical AB provides medical care services. The private company is based in Stockholm, Sweden. | Health Services |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Health Technology |
- Bolsa de valores
- Insiders
- Janna Sand-Dejmek